E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/30/2010 in the Prospect News PIPE Daily.

Anacor Pharmaceuticals wraps $10 million private placement of shares

Deal settles alongside company's $60 million initial public offering

By Devika Patel

Knoxville, Tenn., Nov. 30 - Anacor Pharmaceuticals, Inc. announced it completed a private placement of stock. It raised $10 million.

The company sold 2 million common shares at $5.00 per share. The price per share reflects a 0.6% discount to the Nov. 29 closing share price of $5.03.

The company also said it has completed a $60 million initial public offering of stock at the same price per share.

The pharmaceutical company is based in Palo Alto, Calif.

Issuer:Anacor Pharmaceuticals, Inc.
Issue:Common stock
Amount:$10 million
Units:2 million
Price:$5.00
Warrants:No
Settlement date:Nov. 30
Stock symbol:Nasdaq: ANAC
Stock price:$5.00 at close Nov. 30
Market capitalization:$7.46 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.